Upcoming Trade Shows in France for Medical & Pharma

France continuously invests in research, education, and innovation as means to maintain its place as a leader in the global medical and pharma industry. The French government is keenly aware of the importance of nurturing a skilled workforce and has committed to investing in educational programs that attract international talent. Initiatives like scholarship programs and international academic chairs are designed to bring the best minds from around the world to France, ensuring a continuous flow of knowledge and innovation. The French government is also actively supporting the creation and growth of healthcare-related companies. The ""credit impôt recherche"" (research tax credit) is one of several advantageous tax schemes that provide significant financial incentives for research and development in the healthcare sector. These measures have made France an attractive destination for foreign investors, with a recent EY report indicating that 65% of foreign investors view France as more attractive than other European countries in terms of technological advancements. France's appeal is evident in the sustained investments made by international healthcare giants. Notably, Nordic companies have established a strong presence in the country, with firms like Leo Pharma and Novo Nordisk leading the way. Leo Pharma, a Danish pharmaceutical company, has been operating in France since 1958 and recently invested €22.7 million to expand its production capacity and adopt the latest technologies. Similarly, Novo Nordisk, which has been in France since 1961, celebrated its centennial by investing €130 million and adding 150 new employees at its site in the Centre-Val de Loire region. These investments are not only a testament to France's favorable business environment but also prove the country's strategic importance in the global healthcare landscape. As France continues to enhance its infrastructure, support innovation, and attract international talent, it is well-positioned to remain at the forefront of medical advancements.